Cover Image
Market Research Report

Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018

Published by GlobalData Product code 633263
Published Content info 423 Pages
Delivery time: 1-2 business days
Price
Back to Top
Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018
Published: March 30, 2018 Content info: 423 Pages
Description

GlobalData's clinical trial report, "Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018" provides an overview of Mycobacterium tuberculosis Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Mycobacterium tuberculosis Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC4830CTIDB

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Mycobacterium tuberculosis Infections to Infectious Disease Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Mycobacterium tuberculosis Infections to Infectious Disease Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Mycobacterium tuberculosis Infections Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 421

  • Abbreviations 421
  • Definitions 421
  • Research Methodology 422
  • Secondary Research 422
  • About GlobalData 423
  • Contact Us 423
  • Source 423

List of Tables

  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
  • Proportion of Mycobacterium tuberculosis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 15
  • Mycobacterium tuberculosis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Mycobacterium tuberculosis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Mycobacterium tuberculosis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 18
  • Mycobacterium tuberculosis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Mycobacterium tuberculosis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials by Phase, 2018* 21
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Mycobacterium tuberculosis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures

  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
  • Proportion of Mycobacterium tuberculosis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 15
  • Mycobacterium tuberculosis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Mycobacterium tuberculosis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Mycobacterium tuberculosis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 18
  • Mycobacterium tuberculosis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Mycobacterium tuberculosis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
  • Mycobacterium tuberculosis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Mycobacterium tuberculosis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Mycobacterium tuberculosis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
  • GlobalData Methodology 422
Back to Top